bw a1433u has been researched along with pentoxifylline in 1 studies
Studies (bw a1433u) | Trials (bw a1433u) | Recent Studies (post-2010) (bw a1433u) | Studies (pentoxifylline) | Trials (pentoxifylline) | Recent Studies (post-2010) (pentoxifylline) |
---|---|---|---|---|---|
26 | 0 | 0 | 4,437 | 657 | 943 |
Protein | Taxonomy | bw a1433u (IC50) | pentoxifylline (IC50) |
---|---|---|---|
Acetylcholinesterase | Homo sapiens (human) | 6.6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carper, HT; Hewlett, EL; Hylton, JB; Linden, J; Mandell, GL; Sullivan, GW | 1 |
1 other study(ies) available for bw a1433u and pentoxifylline
Article | Year |
---|---|
Adenosine and related compounds counteract tumor necrosis factor-alpha inhibition of neutrophil migration: implication of a novel cyclic AMP-independent action on the cell surface.
Topics: Actins; Adenosine; Adenosine Deaminase; Cell Movement; Chemotaxis, Leukocyte; Cyclic AMP; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Pentoxifylline; Receptors, Purinergic; Recombinant Proteins; Tumor Necrosis Factor-alpha; Xanthines | 1990 |